의료용 멤브레인 시장

Market Overview
Medical membranes have high precision for separation and assist in the processing of products of high purity. In medical devices, membranes generally exhibit the same properties they present in microfiltration and ultrafiltration processes.
As per DataM Intelligence, Medical Membranes Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Medical Membranes Market size, and growth, along with the latest trends, opportunities, and forecast till 2030 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.
Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. Medical Membranes Market in the United States and Canada produces the utmost share. Whereas the European Medical Membranes Market is projected to continue its presence globally during the period of 2023- 2030.
Medical Membranes Market Trends and Dynamics
Increased application of medical membrane, is expected to drive the global medical membranes market
Membrane technology is of major importance in medical applications, particularly in many lifesaving treatment methods. They are used in drug delivery, artificial organs, tissue regeneration, diagnostic devices, as coatings for medical devices, bioseparations, etc. Various in vitro and in vivo membrane applications, including biosorting, biosensing, immunoisolation and drug delivery are presented. Various types of nanoporous materials and their fabrication techniques are discussed emphasizing membranes with ordered pores.
Desirable membranes used in implantable devices, including biocompatibility and anti-biofouling behavior, are increasing their demand. Despite the extensive research in the characterization, fabrication and modelling of nanoporous materials there are still various challenges that must be overcome to create synthetic nanoporous systems that behave similarly to their biological counterparts. The need for ultra-pure water for pharmaceutical manufacturing and hemodialysis is driving the demand for medical membranes in emerging regions.
Disadvantages associated with membranes is estimated to hamper the market
Although membrane technology is not a new invention, the varying nature and complexity of wastewater will make room for more improvements in terms of efficiency, space requirements, energy, quality of permeate, and technical skills requirements. Again there is a continuous modification of membrane elements and membrane modules to enhance the membrane fouling reduction, a major challenge for membrane processes. The ability to combine two or more membrane processes with other forms of technology like adsorption or coagulation in a hybrid fashion is also continuously being explored, developed and applied in many wastewater treatment facilities. The selection of a suitable membrane and optimization of membrane properties for the identified application are crucial as they dictate the efficiency of removal as well as the cost incurred during the process.
Despite the promise of membrane technologies in addressing various issues related to wastewater treatment, desalination, and energy production, the implementation of membrane processes should be closely monitored to estimate their long-term effects, particularly from an environmental point of view. For example, if the RO feed contains a high concentration of material, it may foul the membrane and reduce the life expectancy. It is a challenge for the market players to produce membranes that last longer or does not foul easily.
COVID-19 Impact on Medical Membranes Market
The COVID-19 pandemic has impacted the medical membrane market. With worldwide lockdown, some of the healthcare sectors have experienced a slight decline in growth rates. In many countries, the economy has dropped due to the halt of several industries, especially transport and supply chain. The demand for the product has been hampered as there is no development due to the lockdown.
Medical Membranes Market Segmentation Analysis
Polysulfone (PSU) & polyethersulfone (PESU) segment is expected to dominate the market over the forecast period
Sulfone polymers or polysulfones (PSUs) are high-temperature thermoplastics that contain a common structural unit, diphenyl sulfone. The polymers of this family are characterized by extraordinary, inherent flame retardancy and high transparency. In the polysulfone family, polyethersulfone is one of the high-temperature engineering thermoplastics. It is an amorphous, transparent thermoplastic. It is tough, rigid, and dimensionally stable over a wide temperature range. The low flammability and smoke generation of PES make it a good candidate to meet FAA regulations for interior aircraft parts. Unreinforced grades are used in high-temperature electrical applications, bakery oven windows, and medical components. The reinforced grades are incorporated in radones, aeroplane components and automotive parts.
It is the second widely used membrane material in MBR. It possesses a higher melting point and thermal stability than the other polymeric membranes by only 1% mass loss in the air at 400°C. Due to its molecular structure besides, PES is more hydrophilic compared to PVDF which facilitates hydrogen bonding with water molecules. Therefore, a higher volume of permeate could be attained using a PES membrane. PES is less tolerant to chlorine but more resistant to NaOCl. Though PES has higher mechanical strength than PVDF membrane, it is more rigid due to little elongation ability. A membrane with high flexibility is important in the MBR application as continuous aeration with high shear force could break the membranes. Therefore, additives are commonly incorporated to increase the flexibility of the membrane in the submerged system. Polysulfone or polyethersulfone membrane filters from Tisch Scientific. These polymers are known for their stability at high temperatures and toughness.
The nanofiltration segment dominated the global medical membranes market
Nanofiltration membranes are applied increasingly to remove DBP precursors such as natural organic matter (NOM), which can react with different disinfectants used in the water treatment process to form potential carcinogens. These membrane devices are specifically designed to eliminate viruses from contaminated sources. In most cases, the working parameters such as flow rate, temperature, nature of the membrane, the load of the virus, and filter area are optimized for efficient and reproducible elimination of the virus of concern. In contrast to the membrane-based virus elimination technique, other separation processes such as chromatographic devices and centrifugation destined for purification of a protein molecule could remove viruses as an accidental phenomenon. The removal mechanism is not purely filtration but also osmotic as the nanofiltration membranes are charged. This makes them a hybrid, bridging ultrafiltration and reverse osmosis membranes in the range of membrane treatment options.
Currently, a wide range of nanofiltration membranes is available in the market, providing numerous options for targeting mass removals of specific or groups of constituents.
The pharmaceutical filtration segment is estimated to dominate the market
Filtration is a widely used process in the pharmaceutical industry to be considered almost omnipresent. For the separation in adsorption, the physical nature of the particles is responsible, while the use of a membrane is involved infiltration. According to Pharma IQ, ultra-filtration is a pressure-driven membrane transport process that is best used in the concentration, separation and purification of specific macromolecules. This method generates a high level of purity in its products, and industrially it is applied to the production of vaccines, and serums. It can be used in a huge variety of applications within the plasma, pharmaceutical industry as it can be scaled up economically and the application of low-shear pumps can reduce the shear denaturation of products.
Recent advances in ultra-filtration are from the biotechnology industry. The character of asymmetric membranes used in ultra-filtration makes them less likely to be clogged by cells or debris than microporous filters, ultra-filtration proves to be a more efficient and cost-effective method for producing biotechnology products. Plasma production is also one of the applications of ultra-filtration. Ultra-filtration is applied to enable this process.
Global Medical Membranes Market Geographical Share
North America region held the largest share in the global medical membranes market
In the United States, government initiatives to support the implementation of manufacturing technologies are motivating the growth of the pharmaceutical filtration market. For instance, the Food and Drug Administration incites pharmaceutical companies to employ manufacturing concepts and provide enhanced approval procedures. The increasing availability of better diagnosis facilities and high incidence and prevalence of chronic diseases is estimated to drive the market in this region.
AXEON Water Technologies is the leading manufacturer of commercial and industrial membrane systems in North America. They offer systems, membranes, cartridges, housings and controls. By offering cost-effective solutions that yield high-quality performance and dependability.
Medical Membranes Companies and Competitive Landscape
The global medical membranes market is moderately competitive with its increasing demand in the pharmaceutical industry.
Major key players in the global medical membranes market are Amniox Medical, Asahi Kasei, Danaher Corporation, Hangzhou Cobetter Filtration Equipment, Koch Membrane Systems, Mann+Hummel, Mann+Hummel, Sartorius AG, W. L. Gore & Associates, 3M Company, among others.
Asahi Kasei
Overview: Asahi Kasei Corporation is a Japanese multinational chemical corporation. Chemicals and materials science are its principal products. It was established in May 1931. It has two operating companies Asahi Kasei Pharma and Veloxis Pharmaceuticals.
Product Portfolio: The company specializes in Health Care, Materials. For example, the company’s Eval ethylene-vinyl alcohol copolymer hollow-fiber membrane for use in medical devices (EVOH) is one of its products.
Key Development: On March 4th 2020, Asahi Kasei completed the acquisition of Veloxis Pharmaceuticals Inc. The company is focused to accelerate its transformation into a global health care company. Along with the newly added management team and employees of Veloxis, Asahi Kasei will maximize the value of both the acquired and existing pharmaceutical businesses.